Intrinsic Value of S&P & Nasdaq Contact Us

iBio, Inc. IBIO NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Score
41/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$2.00
-8.7%

Stock Statistics — IBIO

iBio, Inc. (IBIO) has a market capitalization of $34.58M and trades at $2.19. The 52-week range is 0.56-3.82.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.3, Earnings Per Share (EPS) of $-1.75, annual revenue of $400K.

The stock has a beta of 1.36, operates in the Healthcare sector.

Trading Data
Current Price$2.19
52-Week Range0.56-3.82
Volume446.68K
Avg Volume (30D)1.09M
Market Cap$34.58M
Beta (1Y)1.36
Company
IPO Date2008-08-19
Employees16
CEOMartin Brenner
CountryUS
ExchangeNASDAQ Capital Marke
CurrencyUSD
ISINUS4510337086
CUSIP451033203
Income (Latest Year)
Revenue$400K
Gross Profit$400K
EBITDA$-17.04M
Operating Income$-18.6M
Net Income$-18.38M
EPS$-1.75
EPS Diluted$-1.75
Shares Outstanding$10.5M
Balance Sheet (Latest Year)
Total Assets$23.19M
Current Assets$9.72M
Cash & ST Investments$8.58M
Total Liabilities$8.31M
Total Debt$3.51M
Net Debt$-5.07M
Total Equity$14.88M
Debt / Equity0.24
Valuation Ratios
P/E Ratio-1.3
P/S Ratio86.45
P/B Ratio2.32
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message